What is an AI-powered fertility testing kit business in India?

A home-based diagnostic business offering hormone testing kits (AMH, FSH, LH, Prolactin, thyroid) to assess reproductive health. India has 27.5 million couples with infertility annually, 40% seeking private diagnosis before hospital care. The model involves importing/licensing kits from global manufacturers, white-labeling them, and selling via e-commerce, pharmacies, and fertility clinics.

How much does it cost to start a fertility testing kit business in India?

Minimum ₹2-3 lakh for CDSCO licensing (8-12 weeks). Initial inventory, e-commerce setup, regulatory compliance with CE mark certification, and marketing would require ₹10-20 lakh total. Ongoing costs include product procurement, cold-chain logistics, customer support, and pharmacy/clinic partnerships.

Is the fertility testing kit business profitable in India?

Yes. The addressable market is ₹850 crore annually. With 40% of 27.5M couples (11M) seeking private diagnosis at ₹500-1,500 per test kit, revenue potential is substantial. Gross margins of 40-60% are achievable with direct-to-consumer and B2B2C channels. Repeat testing (baseline, monitoring) increases customer lifetime value.

What regulations apply to fertility testing kits in India?

In-vitro diagnostic devices require CDSCO (Central Drugs Standards Control Organisation) licensing under the Drugs and Cosmetics Act, 1940. Kits must carry CE mark or equivalent international certification. Import requires IEC (Importer Exporter Code). All packaging must comply with MoHFW labeling guidelines. Clinical validation data required for CDSCO approval.

AI Fertility Testing Kits India 2026 | Home Diagnostic Business

AI SummaryThe AI-powered fertility testing kit market in India addresses an ₹850 crore addressable market with 27.5 million couples annually struggling with infertility. In 2026, rising infertility awareness, increasing acceptance of home diagnostics, and 40% preference for private diagnosis before hospital visits create strong market timing. Healthcare entrepreneurs, diagnostic distributors, and fertility clinic chains should pursue this white-label opportunity with CDSCO compliance and e-commerce distribution.